IL66187A0 - 3-methylflavone-8-carboxylic acid esters - Google Patents

3-methylflavone-8-carboxylic acid esters

Info

Publication number
IL66187A0
IL66187A0 IL66187A IL6618782A IL66187A0 IL 66187 A0 IL66187 A0 IL 66187A0 IL 66187 A IL66187 A IL 66187A IL 6618782 A IL6618782 A IL 6618782A IL 66187 A0 IL66187 A0 IL 66187A0
Authority
IL
Israel
Prior art keywords
methylflavone
carboxylic acid
acid esters
esters
carboxylic
Prior art date
Application number
IL66187A
Other languages
English (en)
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of IL66187A0 publication Critical patent/IL66187A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
IL66187A 1981-07-17 1982-07-01 3-methylflavone-8-carboxylic acid esters IL66187A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8122158 1981-07-17

Publications (1)

Publication Number Publication Date
IL66187A0 true IL66187A0 (en) 1982-11-30

Family

ID=10523330

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66187A IL66187A0 (en) 1981-07-17 1982-07-01 3-methylflavone-8-carboxylic acid esters

Country Status (25)

Country Link
US (1) US4550115A (no)
EP (1) EP0072620B1 (no)
JP (1) JPS5835185A (no)
KR (1) KR870000275B1 (no)
AR (1) AR231543A1 (no)
AT (1) ATE16806T1 (no)
AU (1) AU553322B2 (no)
CA (1) CA1221969A (no)
DE (1) DE3267782D1 (no)
DK (1) DK160498C (no)
ES (1) ES8400109A1 (no)
FI (1) FI73677C (no)
GB (1) GB2104507B (no)
GR (1) GR81300B (no)
HU (1) HU189601B (no)
IE (1) IE53525B1 (no)
IL (1) IL66187A0 (no)
IT (1) IT1198389B (no)
NO (1) NO157330C (no)
NZ (1) NZ200981A (no)
PH (1) PH18001A (no)
PT (1) PT75230B (no)
SG (1) SG77784G (no)
YU (2) YU136682A (no)
ZA (1) ZA824335B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225083A (ja) * 1982-06-23 1983-12-27 Nippon Shinyaku Co Ltd メチルフラボン誘導体
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
SG65570A1 (en) 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1258315B (it) * 1992-04-10 1996-02-22 Recordati Chem Pharm Derivati del flavone
US6087366A (en) * 1996-03-07 2000-07-11 The Trustees Of Columbia University In The City Of New York Use of flavopiridol or a pharmaceutically acceptable salt thereof for inhibiting cell damage or cell death
EP1581522B1 (en) 2002-12-23 2008-02-20 Ranbaxy Laboratories Limited Flavaxate derivatives as muscarinic receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US4217351A (en) * 1976-08-04 1980-08-12 Abbott Laboratories Benzopyrano quinuclidines useful as antiglaucoma agents

Also Published As

Publication number Publication date
DK160498B (da) 1991-03-18
CA1221969A (en) 1987-05-19
EP0072620B1 (en) 1985-12-04
FI73677C (fi) 1987-11-09
NZ200981A (en) 1984-10-19
IT8222274A0 (it) 1982-07-07
ZA824335B (en) 1983-05-25
EP0072620A1 (en) 1983-02-23
PT75230A (fr) 1982-08-01
ES513993A0 (es) 1983-10-16
YU136682A (en) 1985-06-30
AR231543A1 (es) 1984-12-28
DK160498C (da) 1991-08-26
JPH0251914B2 (no) 1990-11-08
NO157330B (no) 1987-11-23
PH18001A (en) 1985-02-28
PT75230B (fr) 1984-07-23
FI822493L (fi) 1983-01-18
IE53525B1 (en) 1988-12-07
YU125184A (en) 1985-04-30
US4550115A (en) 1985-10-29
GB2104507A (en) 1983-03-09
IT1198389B (it) 1988-12-21
KR870000275B1 (ko) 1987-02-23
AU553322B2 (en) 1986-07-10
DE3267782D1 (en) 1986-01-16
GB2104507B (en) 1984-09-19
IE821678L (en) 1983-01-17
ES8400109A1 (es) 1983-10-16
GR81300B (no) 1984-12-11
NO822127L (no) 1983-01-18
HU189601B (en) 1986-07-28
KR840000521A (ko) 1984-02-25
ATE16806T1 (de) 1985-12-15
FI73677B (fi) 1987-07-31
SG77784G (en) 1985-04-26
JPS5835185A (ja) 1983-03-01
DK301982A (da) 1983-01-18
FI822493A0 (fi) 1982-07-13
NO157330C (no) 1988-03-02
AU8609882A (en) 1983-01-20

Similar Documents

Publication Publication Date Title
JPS57176941A (en) N-substituted-amide-amino acid
GB2154586B (en) Phenoxyalkanoic acid esters
GB2071665B (en) 18-glycyrrhizinic acid
JPS57165355A (en) Amide-amino acid
GB2095256B (en) Oxazaphosphorin-4-thio-alkanesulphonic acids
GB2104507B (en) 3-methylflavone-8-carboxylic acid esters
GB2102415B (en) Apovincaminic acid esters
GB2103232B (en) Arylazo-aminonaphtholsulfonic acid
GB2080288B (en) 4-methoxy-isophthalic acid picolylamide monohydrate
GB2110208B (en) Vincaminic acid esters
GB2106516B (en) Anthranilic acid esters
JPS57175161A (en) Prostanic acid derivative
GB2162514B (en) Thiazolylpropenedicarboxylic acid half esters
JPS57169461A (en) Phenoxypyridylmethyl esters
ZA859517B (en) Pyrimidinyl-thionophosphoric acid esters
ZA859601B (en) Pyridyl-thionophosphoric acid esters
ZA825511B (en) Process for the preparation of-hydroxy-phosphonic acid esters
NZ210827A (en) Pregn-5-en-21-0ic acid esters
IE812835L (en) N-pyrimidinyl-carbamic acid esters
JPS5745152A (en) Halogenomethylsulfonylphenyl-phthalamine acid
ZA855262B (en) Pyrimidinyl-thionophosphoric acid esters
GB2095238B (en) 7-acylamido-3-cephem-4-carboxylic acid compounds
GB8328516D0 (en) Preparing perfluoroacrylic acid ester
IE812853L (en) Phenyl-hydrazino-2-cyanoacrylic acid esters.
DE3366930D1 (en) New phenylthionophosphonic acid esters

Legal Events

Date Code Title Description
RH Patent void